Monte Carlo design study of a moderated 252Cf source for in vivo neutron activation analysis of aluminium

Physics in Medicine and Biology

Volumn 42, Issue 4, 1997, Pages 625-636

  Lewis, D G ^a   Natto, S S A ^a,c   Ryde, S J S ^b   Evans, C J ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SINGLETON HOSPITAL   (United Kingdom)

^c UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; CALIFORNIUM 252;

ARTICLE; COMPUTER PROGRAM; NEUTRON ACTIVATION ANALYSIS; PRIORITY JOURNAL;

ALUMINUM; CALIFORNIUM; DEUTERIUM OXIDE; GAMMA RAYS; HAND; HUMANS; MONTE CARLO METHOD; NEUTRON ACTIVATION ANALYSIS; PHANTOMS, IMAGING; SKIN;

EID: 0030961964     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/42/4/002     Document Type: Article

References (22)

1. Altmann P, Dhanesha U, Hamon J, Blair J, Cunningham J and Marsh F 1989 Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity The Lancet 334 7-12
2. Briesmeister J F 1993 MCNP - a general Monte Carlo code for neutron and photon transport Los Alamos National Laboratory Report LA 7396-M
3. Chettle D R and Fremlin J H 1984 Techniques of in vivo neutron activation analysis Phys. Med. Biol. 29 1111-43
4. Ellis K J, Kelleher S, Raciti A, Savory J and Wills M 1988 In vivo monitoring of skeletal aluminium burden in patients with renal failure J. Radioanal. Nucl. Chem. 124 85-95
5. Green S and Chettle D R 1992 A feasibility study of the in vivo measurement of aluminium in peripheral bone Phys. Med. Biol. 37 2287-96
6. ICRP 1974 Report of the Task Group on Reference Man International Commission on Radiological Protection Publication 23 (Oxford: Pergamon)
7. _ 1990 International Commission on Radiological Protection Publication 60 (Oxford: Pergamon)
8. Krishnaswamy V 1971 Calculation of the dose distribution about californium-252 needles in tissue Radiology 98 155-60
9. Malluche H and Faugere MC 1990 Renal bone disease 1990: an unmet challenge for the nephrologist Kidney Int. 38 193-211
10. Mattsson S, Christofferson J O, Jonson R, and Nilsson U 1987 X-ray fluorescence technique for in vivo analysis of natural and administered trace elements In Vivo Body Composition Studies ed K J Ellis, S Yasamura and W D Morgan (London: IPSM) pp 318-24
11. McLane V, Dunford CL and Rose PF 1988 Neutron Cross Sections (New York: Academic)
12. Nagarajan PS, Dayashankar and Venkataraman G 1971 Neutron dose distributions for californium-252 sources Int. J. Appl. Radiat. Isotopes 22 325-9
13. Natto S S A 1996 PhD Thesis (University of Wales)
14. NBS 1957 US National Bureau of Standards Handbook no 63
15. NRPB 1989 National Radiation Protection Board: Living with Radiation (London: HMSO)
16. O'Hare J A and Murnughan D J 1982 Reversal of aluminium induced hemodialysis anemia by a low aluminium dialysate New Engl. J. Med. 306 654-8
17. Palerme S, Chettle DR, Kennett TJ, Prestwich WV and Webber CE 1992 Pilot studies for in vivo bone aluminium measurements Human Body Composition: In Vivo Methods, Models and Assessment ed K J Ellis and J D Eastman (New York: Plenum) pp 303-6
18. 252Cf Phys. Med. Biol. 32 1257-71
19. Williams E D, Elliott H L, Boddy K, Haywood J K, Henderson I S, Harvey I and Kennedy A C 1980 Whole body aluminium in chronic renal failure and dialysis encephalopathy Clin. Nephrol. 14 198-200
20. Wyatt R M, Ryde S J S, Morgan W D, McNeil E A, Hainsworth I R and Williams A J 1993 The development of a technique to measure bone aluminium content using neutron activation analysis Physiol. Meas. 14 327-35
21. Yanch J C, Kim J K and Wilson M K 1993 Design of a californium-based epithermal neutron beam for neutron capture therapy Phys. Med. Biol. 38 1145-55
22. 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy Radiat. Res. 131 249-56